IRIX
IRIDEX CorporationNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$17.83M
P/E Ratio
—
EPS
$-0.26
Beta
0.76
52W High
$1.65
52W Low
$0.87
50-Day MA
$1.35
200-Day MA
$1.19
Dividend Yield
—
Profit Margin
-8.42%
Forward P/E
769.23
PEG Ratio
0.94
About IRIDEX Corporation
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic laser systems, delivery devices, and consumable instrumentation to treat vision-threatening eye diseases in ophthalmology. The company is headquartered in Mountain View, California.
Fundamentals
| Revenue (TTM) | $52.67M |
| Gross Profit (TTM) | $19.23M |
| EBITDA | $-2.08M |
| Operating Margin | -0.10% |
| Return on Equity | -126.40% |
| Return on Assets | -5.51% |
| Revenue/Share (TTM) | $3.11 |
| Book Value | $-0.06 |
| Price-to-Book | 269.77 |
| Price-to-Sales (TTM) | 0.34 |
| EV/Revenue | 0.407 |
| EV/EBITDA | -3.61 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 16.00% |
| Shares Outstanding | $17.31M |
| Float | $10.92M |
| % Insiders | 29.83% |
| % Institutions | 17.76% |
Analyst Ratings
Consensus ($2.75 target)
1
BuyData last updated: 4/8/2026